![](/img/cover-not-exists.png)
Treatment with mipomersen reduces levels of apoB-containing lipoproteins by increasing fractional removal of VLDL and LDL-apoB without reducing vldl-apob secretion
Soffer, G., Dionizovik, M., Jimenez, J., Holleran, S., Ramakrishnan, S., Karmally, W., Fontanez, N., Donovan, D., Morey, R., Mittleman, R., Chin, W., Baker, B., Ginsberg, H.Volume:
235
Language:
english
Journal:
Atherosclerosis
DOI:
10.1016/j.atherosclerosis.2014.05.148
Date:
August, 2014
File:
PDF, 53 KB
english, 2014